Gary Leatt serves as Executive at Acer Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Gary Leatt has executed 3 insider transactions totaling $4.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 12, 2017 involved purchasing 21,271 shares valued at $255.3K.
Gary Leatt currently holds 248,756 shares of Acer Therapeutics Inc. (ACER), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary Leatt has been a net buyer of ACER stock. They have purchased $4.0M and sold $0 worth of shares.
Gary Leatt's most recent insider trade was on Dec 12, 2017, when they purchased 21,271 shares at $12.00 per share.
Get notified when new Form 4 filings are submitted
| $12.00 |
| Discretionary |
| Dec 12, 2017 | ACER | $744.7K | Purchase | 62,062 | $12.00 | Discretionary |